ClinicalTrials.gg
Sign In

Constriction, Pathologic clinical trials

The registry lists 456 studies for Constriction, Pathologic across more than 10 countries. 109 are recruiting or about to start. 295 of them are mainly about Constriction, Pathologic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Constriction, Pathologic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
201
Status unknown
72
Recruiting
67
Terminated
37
Not yet recruiting
32
Active, not recruiting
20

Phase

Phase 3
24
Phase 2
24
Phase 4
22
Phase 1
14
Early Phase 1
2

Where

United States
116
China
80
Germany
43
France
36
Italy
23
Belgium
21

Who runs them

Boston Scientific Corporation (12) · C. R. Bard (11) · Mayo Clinic (7) · Assiut University (7) · W.L.Gore & Associates (6) · Singapore General Hospital (6) · Second Affiliated Hospital, School of Medicine, Zhejiang University (5) · Stanford University (4)

What is being tested here

Drugs under test in Constriction, Pathologic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Sirolimus113
Azathioprine101
Infliximab101
Rivaroxaban111
Alirocumab111
Triamcinolone111
Cholesterol-binding protein002
Dupilumab001
Nepafenac001
Paclitaxel001

Coming up

7phase 3 studies under way
40studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 67 Constriction, Pathologic studies recruiting now, 34 (51%) set no upper age limit and 14 (21%) stop at 75 or younger. 8 (12%) take children under 18. 0 (0%) are for women only and 2 (3%) for men only; 1 (1%) take healthy volunteers.

Recruiting studies that take each age, of 67
AgeWomenMen
106 (9%)6 (9%)
1855 (82%)57 (85%)
3058 (87%)60 (90%)
4061 (91%)63 (94%)
5063 (94%)65 (97%)
6561 (91%)63 (94%)
7556 (84%)58 (87%)
8538 (57%)40 (60%)

Across all 456 studies, recruiting or not: 15% stop at 75 or younger and 6% at 65; 12% take children; 1% are for women only and 2% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Constriction, Pathologic studies take

Of 133 interventional studies with no phase under Constriction, Pathologic, half reached primary completion within 36 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase36 mo18–53 · 133 studies34 mo18–58 · 43 studies36 mo19–49 · 90 studies
Observational31 mo19–62 · 64 studies—31 mo19–62 · 52 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 456. Browse all 456 → or search them.